Barclays’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-600
Closed -$36K 7139
2018
Q4
$36K Buy
+600
New +$48.4K ﹤0.01% 5640
2017
Q2
Sell
-25,000
Closed -$1.06M 6758
2017
Q1
$1.06M Hold
25,000
﹤0.01% 2677
2016
Q4
$1.01M Buy
+25,000
New +$966K ﹤0.01% 2735

Other funds holding HQY

Barclays's HQY Position: Q1 2026 in Review

Barclays reduced its HealthEquity (HQY) stake by 73% in Q1 2026, selling an estimated $11.1M and leaving 50,122 shares worth $4.19M. The position accounts for ﹤0.01% of the portfolio, ranked #1928.

Barclays first reported a position in HQY in Q4 2014 and has held it in 44 quarters since. The position peaked at $21M in Q2 2025. 485 funds tracked by Wall St. Rank hold HQY as of Q1 2026.

  • Barclays held 50,122 shares of HealthEquity worth $4.19M as of Q1 2026.
  • Barclays sold 134,982 HealthEquity shares in Q1 2026, an estimated $11.1M.
  • HealthEquity made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #1928 holding.
  • Barclays first reported a position in HealthEquity in Q4 2014 and has held it in 44 quarters since.
  • Barclays's HealthEquity position peaked at $21M in Q2 2025.
  • 485 funds tracked by Wall St. Rank held HealthEquity as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.